Get started
SYNCOM FORMULATIONS (INDIA) LTSYNCOM FORMULATIONS (INDIA) LTSYNCOM FORMULATIONS (INDIA) LT

SYNCOM FORMULATIONS (INDIA) LT

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

SYNCOMF chart


Full chart

Key stats


Market capitalization
‪17.02 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
53.57
Basic EPS (TTM)
0.35 INR
Net income (FY)
‪253.14 M‬ INR
Revenue (FY)
‪2.59 B‬ INR
Shares float
‪463.51 M‬
Beta (1Y)
1.49

Employees


Employees (FY)
‪1.32 K‬
Change (1Y)
+525 +65.71%
Revenue / Employee (1Y)
‪1.96 M‬ INR
Net income / Employee (1Y)
‪191.19 K‬ INR

About SYNCOM FORMU (I) LTD


Sector
Health Technology
CEO
Vijay Shankarlal Bankda
Headquarters
Indore
Website
syncomformulations.com
Founded
1988
ISIN
INE312C01025
FIGI
BBG000D7VG18
Syncom Formulations (India) Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company operates through the following segments: Pharmaceutical Drugs and Formulations, Trading of Commodities, and Renting of Property. The company was founded by Kedarmal Shankarlal Bankda, Ajay Kumar Bankda, and Vijay Shankarlal Bankda on June 21, 1988 and is headquartered in Indore, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SYNCOMF news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SYNCOMF is 18.11 INR — it has decreased by −4.13% in the past 24 hours. Watch SYNCOM FORMULATIONS (INDIA) LT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SYNCOM FORMULATIONS (INDIA) LT stocks are traded under the ticker SYNCOMF.
SYNCOMF stock has fallen by −12.26% compared to the previous week, the month change is a −20.60% fall, over the last year SYNCOM FORMULATIONS (INDIA) LT has showed a 8.77% increase.
SYNCOMF reached its all-time high on Sep 10, 2024 with the price of 27.94 INR, and its all-time low was 0.15 INR and was reached on Aug 13, 2013. View more price dynamics on SYNCOMF chart.
See other stocks reaching their highest and lowest prices.
SYNCOMF stock is 5.16% volatile and has beta coefficient of 1.49. Track SYNCOM FORMULATIONS (INDIA) LT stock price on the chart and check out the list of the most volatile stocks — is SYNCOM FORMULATIONS (INDIA) LT there?
Today SYNCOM FORMULATIONS (INDIA) LT has the market capitalization of ‪17.02 B‬, it has decreased by −4.60% over the last week.
Yes, you can track SYNCOM FORMULATIONS (INDIA) LT financials in yearly and quarterly reports right on TradingView.
SYNCOMF net income for the last quarter is ‪111.08 M‬ INR, while the quarter before that showed ‪76.33 M‬ INR of net income which accounts for 45.54% change. Track more SYNCOM FORMULATIONS (INDIA) LT financial stats to get the full picture.
SYNCOM FORMULATIONS (INDIA) LT dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jan 12, 2025, the company has ‪1.32 K‬ employees. See our rating of the largest employees — is SYNCOM FORMULATIONS (INDIA) LT on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNCOM FORMULATIONS (INDIA) LT EBITDA is ‪393.97 M‬ INR, and current EBITDA margin is 10.07%. See more stats in SYNCOM FORMULATIONS (INDIA) LT financial statements.
Like other stocks, SYNCOMF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNCOM FORMULATIONS (INDIA) LT stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNCOM FORMULATIONS (INDIA) LT technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNCOM FORMULATIONS (INDIA) LT stock shows the strong buy signal. See more of SYNCOM FORMULATIONS (INDIA) LT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.